InvestorsHub Logo
Followers 34
Posts 3031
Boards Moderated 0
Alias Born 02/27/2016

Re: None

Monday, 11/14/2022 8:44:57 AM

Monday, November 14, 2022 8:44:57 AM

Post# of 470679
https://www.reuters.com/business/healthcare-pharmaceuticals/roche-says-phase-iii-trial-alzheimers-trial-drug-fails-2022-11-14/

Roche's trial failure "takes out the biggest competitive risk to lecanemab," Baird analyst Brian Skorney said in a note.

Ha!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News